Page 2 - Core Instructions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: Amid the vaccine roll out, 97,309 new cases of COVID-19 have been reported to the CDC. Peter Staats, M.D. Chief Medical Officer of electroCore, Inc. (NASDAQ:ECOR), outlines common COVID-19 symptoms and at-home steps that can be discussed with health care providers to reduce symptoms. At-home steps to reduce COVID-19 symptoms: Confusion and Brain Fog: Although brain fog is not a true medical condition, it is a common symptom for many COVID-19 patients. Confusion and brain fog can be very frustrating and cause forgetfulness, cognitive decline, memory problems, inability to focus, hazines...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to ... electroCoreFebruary 9, 2021 GMT ROCKAWAY, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer reviewed paper, entitled: “Non-invasive vagus nerve stimulation to reduce ileus after major colorectal surgery: Early development study” in the journal Colorectal Disease. The paper reports on...

Published: Feb 02, 2021 ROCKAWAY, N.J., Feb. 02, 2021 (GLOBE NEWSWIRE) -- electroCore Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that full enrollment has been achieved for the TR-VENUS study of non-invasive vagal nerve stimulation (nVNS) for the acute treatment of stroke. TR-VENUS is a double blind, randomized, sham-controlled, multi-center clinical trial, conducted at nine major medical centers across Turkey, supported by the Turkish Neurological Society and partially funded through an unrestricted research grant from electroCore. Stroke is t...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. electroCore, Inc. Announces Agreement with Pro Medical Baltic to be Exclusive Distributor for ... electroCoreDecember 21, 2020 GMT ROCKAWAY, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has entered into an agreement with Pro Medical Baltic UAB (“PMB”), whereby PMB will serve as the exclusive distributor of gammaCore Sapphire™ non-invasive vagus nerve stimulation (“nVNS”) to patients s...

electroCore Announces Positive Top-Line Results from PREMIUM II Migraine Prevention Study December 08, 2020 08:00 ET | Source: electroCore electroCore Basking Ridge, New Jersey, UNITED STATES BASKING RIDGE, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today top-line results from its GM-US-10 (PREMIUM II) study. Despite the early termination of the study in April 2020 due to the COVID-19 pandemic, all study endpoints, including several patient-assessed qualit...